Hacker News new | ask | show | jobs
by FeteCommuniste 21 days ago
Yes. Potentially life-saving drugs in RCTs are usually compared to "standard of care," i.e. already-approved treatments, not to placebos.
1 comments

So if both the standard of care as well as the drug being trials have the same side effects, would they be included in the package insert/drug literature? Because the incidence rate of it would be same for both the groups?